Investment Committee – October 15, 2018
Sale of MatrixCare
OMERS Private Equity sought the approval of the Investment Committee to proceed with the disposition of the OAC’s indirect interest in MatrixCare, an industry leading, SaaS-based, long-term post-acute care technology provider used in more than 13,000 facility-based care settings and 2,500 home care, home health and hospice organizations.
Following a question and discussion period, the Investment Committee approved the sale.
In a press release issued November 5, 2018, OMERS and OMERS Private Equity announced the sale of MatrixCare to ResMed Operations Inc. for US$750 million. The transaction closed in the fourth quarter of 2018.